Non-Invasive Blood Glucose Monitoring Devices Market By Technology (Bio-impedance spectroscopy, Electromagnetic sensing, Fluorescence, Mid-infrared / Near infrared spectroscopy, Optical coherence tomography, Optical polarimetry, Raman spectroscopy, Revers

Non-Invasive Blood Glucose Monitoring Devices Market By Technology (Bio-impedance spectroscopy, Electromagnetic sensing, Fluorescence, Mid-infrared / Near infrared spectroscopy, Optical coherence tomography, Optical polarimetry, Raman spectroscopy, Reverse iontophoresis and Ultrasound technology) By Modality (Wearable and Non-wearable / table top) By End Users (Hospitals & Clinics, Diagnostic Centers and Homecare Setting) - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022 - 2028

The development of non-invasive glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, less invasively than conventional glucose monitoring devices. Non-invasive glucose monitoring automatically and constantly tracks blood glucose levels throughout the day, thus providing information that can be analysed to make informed decisions about managing dietary habits, physical activity, and medication.
Moreover, with non-invasive glucose monitoring devices, one can perform an unlimited amount of measurements and evaluate blood glucose level as it changes throughout the day, as well as overnight.
Market Dynamics
Non-invasive glucose monitoring holds great promise for improving diabetes management by providing better and pain-free blood glucose measurement. Moreover, increasing prevalence of diabetes is expected to drive growth of the market. For instance, according to World Health Organisation (WHO), in 2014, diabetes mellitus, a worldwide epidemic disease affected 422 million people and became the seventh leading cause of death in the U.S.
Healthcare regulatory bodies are focused on increasing awareness regarding continuous glucose monitoring, which will help in the adoption of non-invasive glucose monitoring devices in near future. For instance, National Diabetes Strategy (2016-20) has been developed in Australia to guide national action and priorities to prevent diabetes and support the people suffering from diabetes. However, less accuracy of non-invasive blood glucose monitoring devices can negatively impact the adoption rate of the product in future.
Key features of the study:
This report provides in-depth analysis of the non-invasive blood glucose monitoring devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for non-invasive blood glucose monitoring devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality:
Wearable
Non-wearable
Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User:
Hospitals
Home Care Settings
Clinics
Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region:
North America
By Country:
U.S.
Canada
By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
By Modality:
Wearable
Non-wearable
By End User:
Hospitals
Home Care Settings
Clinics
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
By Modality:
Wearable
Non-wearable
By End User:
Hospitals
Home Care Settings
Clinics
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
By Modality:
Wearable
Non-wearable
By End User:
Hospitals
Home Care Settings
Clinics
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
By Modality:
Wearable
Non-wearable
By End User:
Hospitals
Home Care Settings
Clinics
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
By Modality:
Wearable
Non-wearable
By End User:
Hospitals
Home Care Settings
Clinics
Africa
By Country:
South Africa
Central Africa
North Africa
By Technology:
Optical
Infrared Spectroscopy
Raman Spectroscopy
Transdermal
Impedance Spectroscopy
Reverse iontophoresis
Enzymatic
Others
By Modality:
Wearable
Non-wearable
By End User:
Hospitals
Home Care Settings
Clinics
Company Profiles
DiaMonTech GmbH*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Nemaura Medical Inc.
Integrity Applications, Inc.
CNOGA Medical Ltd.
Breath Health, Inc.
Metamaterial Technologies Inc.
Opticology Inc.
NovioSense BV
Quick LLC
RSP Systems A/S
“*” marked represents similar segmentation in other categories in the respective section.